Plenary Session II

Tuesday, May 1
9:35 am - 1:00 pm
Location:

Moderator(s): Frederick G. Barker II, MD, FAANS; Alex B. Valadka, MD, FAANS


9:35 am - 9:44 am

New Orleans Rising – Hurricane Katrina and its Aftermath – Presented by Dr. David Kline

Historical Film

9:45 am - 9:47 am

Introduction of the Rhoton Family Lecture

Alex B. Valadka, MD, FAANS

9:48 am - 10:18 am

Rhoton Family Lecture

Daniel H. Pink, JD

10:19 am - 10:26 am

Complete 6-Month Primary Endpoint Results from the Prospective INSPIRE Study of the Investigational Neuro-Spinal Scaffold™ in Acute Thoracic Complete Spinal Cord Injury

K. Stuart Lee, MD, FAANS

10:27 am - 10:29 am

Discussant

Sanjay Dhall, MD, FAANS

10:30 am - 10:37 am

INTREPID: A Prospective, Double Blinded, Multicenter Randomized Controlled Trial Evaluating Deep Brain Stimulation with a New Multiple Source, Constant Current Rechargeable System in Parkinson’s disease

Robert E. Gross, MD, PhD, FAANS

10:38 am - 10:40 am

Discussant

Aviva Abosch, MD, PhD, FAANS

10:41 am - 10:51 am

613. The Roles of Rhythm and Prediction in Speech Perception

Nitin Tandon, MD, FAANS

10:52 am - 10:54 am

Discussant

Daniel Yoshor, MD, FAANS

10:55 am - 11:05 am

614. Change in policy allowing overlapping surgery decreases length of stay in an academic, safety-net hospital.

Anthony DiGiorgio, DO

11:06 am - 11:07 am

Assessment of the Trial Design/Level of Evidence

Frederick G. Barker II, MD, FAANS

11:08 am - 11:10 am

Discussant

William T. Couldwell, MD, PhD, FAANS

11:11 am - 11:14 am

JNS Update

James T. Rutka, MD, PhD, FAANS (Canada)

11:15 am - 11:17 am

Introduction of the International Lifetime Recognition Award

Alex B. Valadka, MD, FAANS

11:18 am - 11:20 am

International Lifetime Recognition Award

Jeffrey V. Rosenfeld,, MS, IFAANS (Australia)

11:21 am - 11:31 am

AANS Featured Speaker: International Lifetime Recognition Award Winner

Jeffrey V. Rosenfeld,, MS, IFAANS (Australia)

11:32 am - 11:42 am

615. Evaluation of Durable Response Rate in the Post-Resection Setting and Association with Survival in Patients with Recurrent High Grade Glioma who Received Vocimagene Amiretroprepvec and 5-Fluorocytosine Treatment

Bob S. Carter, MD, PhD, FAANS

11:43 am - 11:44 am

Assessment of the Trial Design/Level of Evidence

Frederick G. Barker II, MD, FAANS

11:45 am - 11:47 am

Discussant

James M. Markert Jr., MD, FAANS

11:48 am - 11:58 am

616. Modified Risk Prediction Model for the Open Treatment of Unruptured Cerebral Aneurysms in Japan: UCAS-Treat result and model verification using UCAS II outcome

Akio Morita, MD, PhD, IFAANS (Japan)

11:59 am - 12:00 pm

Assessment of the Trial Design/Level of Evidence

Frederick G. Barker II, MD, FAANS

12:01 pm - 12:03 pm

Discussant

Sepideh Amin-Hanjani, MD, FAANS

12:04 pm - 12:07 pm

CNS Update

Ashwini D. Sharan, MD, FAANS

12:08 pm - 12:10 pm

Introduction of the Cushing Medalist

Alex B. Valadka, MD, FAANS

12:11 pm - 12:15 pm

Cushing Medalist

James R. Bean, MD, FAANS

12:16 pm - 12:17 pm

Introduction of the Cushing Orator

James M. Ecklund, MD, FAANS

12:18 pm - 12:58 pm

Cushing Orator

Gen. Stan McChrystal

12:59 pm - 1:00 pm

Introduction of the Lunch and Learn Seminars

Frederick G. Barker II, MD, FAANS